Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations

Cytogenetics and Cell Genetics

Volumn 83, Issue 3-4, 1998, Pages 266-269

  Weber, R G ^a,b   Bridger, J M ^a   Benner, A ^b   Weisenberger, D ^a   Ehemann, V ^c   Reifenberger, G ^d   Lichter, P ^a  

^a Abteilung Organisation Komplexer Genome   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

AGED; ARTICLE; CASE REPORT; CENTROSOME; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; INFANT; MALE; NEUROECTODERM TUMOR; NUMERICAL CHROMOSOME ABERRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032463109     PISSN: 03010171     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015168     Document Type: Article

References (15)

1. Cox LS, Lane DP: Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. BioEssays 17:501-508 (1995).
2. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ: A p53-dependent mouse spindle checkpoint. Science 267:1353-1356 (1995).
3. Du Manoir S, Kallioniemi OP, Lichter P, Piper J, Benedetti PA, Carothers AD, Fantes JA, Garcia-Sagredo JM, Gerdes T, Giollant M, Hemery B, Isola J, Maahr J, Morrison H, Perry P, Stark M, Sudar D, van Vliet LJ, Verwoerd N, Vrolijk J: Hardware and software requirements for quantitative analysis of comparative genomic hybridization. Cytometry 19:4-9 (1995).
4. Du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T: Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590-610 (1993).
5. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF: Abnormal centrosome amplification in the absence of p53. Science 271:1744-1747 (1996).
6. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333-1335 (1983).
7. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821 (1992).
8. Kleihues P, Burger PC, Scheithauer B: Histological typing of tumours of the central nervous system (Springer-Verlag, Berlin/Heidelberg/New York 1993).
9. Levine DS, Sanchez CA, Rabinovitch PS, Reid BJ: Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc natl Acad Sci, USA 88:6427-6431 (1991).
10. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88:323-331 (1997).
11. Mitelman F, Johansson B, Mertens F: Catalog of Chromosome Aberrations in Cancer: An Interactive Database on CD-ROM (John Wiley & Sons, New York 1998).
12. Otto FJ: High resolution analysis of nuclear DNA employing the fluorochrome DAPI. Meth Cell Biol 41:211-217 (1994).
13. Reifenberger J, Janssen G, Weber RG, Boström J, Engelbrecht V, Lichter P, Borchard F, Göbel U, Lenard HG, Reifenberger G: Primitive neuroectodermal tumors of the cerebral hemispheres in two siblings with TP53 germline mutation. J Neuropathol exp Neural 57:179-187 (1998).
14. Zhou H, Kuang J, Zhong L, Kuo W, Gray JW, Sahin A, Brinkley BR, Sen S: Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genet 20:189-193 (1998).
15. Zitzelsberger H, Lehmann L, Wemer M, Bauchinger M: Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies. Histochem Cell Biol 108:403-417 (1997).